{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T10:17:17Z","timestamp":1768990637568,"version":"3.49.0"},"reference-count":17,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DD&T"],"published-print":{"date-parts":[[2017]]},"DOI":"10.5582\/ddt.2017.01043","type":"journal-article","created":{"date-parts":[[2017,9,3]],"date-time":"2017-09-03T18:07:48Z","timestamp":1504462068000},"page":"218-222","source":"Crossref","is-referenced-by-count":6,"title":["Successful treatment of three patients with organizing pneumonia associated with rheumatoid arthritis using clarithromycin and prednisolone"],"prefix":"10.5582","volume":"11","author":[{"given":"Masashi","family":"Ohe","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, JCHO Hokkaido Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruki","family":"Shida","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, JCHO Hokkaido Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Horita","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, JCHO Hokkaido Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichiro","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, JCHO Hokkaido Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Sugiura","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology, JCHO Hokkaido Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuo","family":"Hattori","sequence":"additional","affiliation":[{"name":"Department of Pathology, JCHO Hokkaido Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Oku","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Endocrinology and Nephrology, Hokkaido University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3542","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Epler GR, Colby TV, McLoud TC, Carrington CB, Gaensler EA. Bronchiolitis obliterans organizing pneumonia. N Engl J Med. 1985; 312:152-158.","DOI":"10.1056\/NEJM198501173120304"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Epler GR. Bronchiolitis obliterans organizing pneumonia. Arch Intern Med. 2001; 161:158-164.","DOI":"10.1001\/archinte.161.2.158"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kudoh S, Azuma A, Yamamoto M, Izumi T, Ando M. Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. Am J Respir Crit Care Med. 1998; 157:1829-1832.","DOI":"10.1164\/ajrccm.157.6.9710075"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Tsang KW, Ho PI, Chan KN, Ip MS, Lam WK, Ho CS, Yuen KY, Ooi GC, Amitani R, Tanaka E. A pilot study of low-dose erythromycin in bronchiectasis. Eur Respir J. 1999; 13:361-364.","DOI":"10.1183\/09031936.99.13236199"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Wolter J, Seeney S, Bell S, Bowler S, Masel P, McCormack J. Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: A randomized trial. Thorax. 2002; 57:212-216.","DOI":"10.1136\/thorax.57.3.212"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Ichikawa Y, Ninomiya H, Katsuki M, Hotta M, Tanaka M, Oizumi K. Low-dose\/long-term erythromycin for treatment of bronchiolitis obliterans organizing pneumonia (BOOP). Kurume Med J. 1993; 91:65-67.","DOI":"10.2739\/kurumemedj.40.65"},{"key":"7","unstructured":"7. Stover DE, Mangino D. Macrolides: A treatment alternative for bronchiolitis obliterance organizing pneumonia? Chest. 2005; 128:3611-3617."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Lee J, Cha SI, Park TI, Park JY, Jung TH, Kim CH. Adjunctive effects of cyclosporine and macrolide in rapidly progressive cryptogenic organizing pneumonia with no prompt response to steroid. Intern Med. 2011; 50:475-479.","DOI":"10.2169\/internalmedicine.50.4237"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Oh JH, Oh DJ, Koo SM, Kim YK, Kim KU, Kim HJ, Kim DW, Uh ST. Different responses to clarithromycin in patients with cryptogenic organizing pneumonia. Tuberc Resp Dis. 2015; 78:401-407.","DOI":"10.4046\/trd.2015.78.4.401"},{"key":"10","unstructured":"10. Saviola G, Abdi Ali L, Rossini P, Campostrini L, Coppini A, Goli M, Ianaro A, Bucci M, de Nucci G, Cirino G. Clarithromycin in rheumatoid arthritis patients not responsive to disease-modifying antirheumatic drugs: An open, uncontrolled pilot study. Clin Exp Rheumatol. 2002; 20:373-378."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kim SJ, Lee KS, Ryu YH, Yoon YC, Choe KO, Kim TS, Sung KJ. Reversed halo sign on high-resolution CT of cryptogenic organizing pneumonia: Diagnostic implications. Am J Roentgenol. 2003; 180:1251-1254.","DOI":"10.2214\/ajr.180.5.1801251"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Purcell IF, Bourke SJ, Marshall SM. Cyclophosphamide in severe steroid-resistant bronchiolitis obliterans organizing pneumonia. Respir Med. 1997; 91:175-177.","DOI":"10.1016\/S0954-6111(97)90055-X"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Koinuma D, Miki M, Ebina M, Tahara M, Hagiwara K, Kondo T, Taguchi Y, Nukiwa T. Successful treatment of a case with rapidly progressive bronchiolitis obliterans organizing pneumonia (BOOP) using cyclosporin A and corticosteroid. Intern Med. 2002; 41:26-29.","DOI":"10.2169\/internalmedicine.41.26"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Sakito O, Kadota J, Kohno S, Abe K, Shirai R, Hara K. Interleukin 1\u03b2, tumor necrosis factor \u03b1, and interleukin 8 in brochoalveolar lavage fluid of patients with diffuse panbronchiolitis: A potential mechanism of macrolide therapy. Respiration.1996; 63:42-48.","DOI":"10.1159\/000196514"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Aoki Y, Kao PN. Erythromycin inhibits transcriptional activation of NF-\u03baB, but not NFAT, through calcineurin-independent signaling in T-cells. Antimicrob Agents Chemother. 1999; 43:2678-2684.","DOI":"10.1128\/AAC.43.11.2678"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Ding QL, LV D, Wang BJ, Zhang QL, Yu YM, Sun SF, Chen ZB, Ma HY, Deng ZC. Macrolide therapy in cryptogenic organizing pneumonia: A case report and literature review. Exp Ther Med. 2015; 9:829-834.","DOI":"10.3892\/etm.2015.2183"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Mori S, Koga Y, Sugimoto M. Organizing pneumonia in rheumatoid arthritis patients: A case-based review. Clin Med Insights Circ Respir Pulm Med. 2015; 9:69-80.","DOI":"10.4137\/CCRPM.S23327"}],"container-title":["Drug Discoveries & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ddt\/11\/4\/11_2017.01043\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T23:08:54Z","timestamp":1570057734000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ddt\/11\/4\/11_2017.01043\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.5582\/ddt.2017.01043","relation":{},"ISSN":["1881-7831","1881-784X"],"issn-type":[{"value":"1881-7831","type":"print"},{"value":"1881-784X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}